Maneesh Jain

Maneesh Jain is a prominent leader in the biotechnology and healthcare sectors, currently serving as CEO and Co-founder of Mirvie, a company focused on addressing pregnancy complications through innovative liquid biopsy technologies. Jain also holds board positions at Mammoth Biosciences, Adela, and Mission Bio, contributing to advancements in CRISPR applications, early cancer detection, and single-cell analysis platforms. As CEO and President of Cirina Inc., Jain was instrumental in developing the first non-invasive blood test for early cancer detection. Jain's leadership roles extend to Butterfly Network, where a portable ultrasound device was commercialized, and as an angel investor with Life Science Angels. An academic background includes a PhD in Applied Physics from Stanford University and a BSc in Physics/EE from Caltech.